|Brand name(s), other common name(s)||Vumon®, VM-26|
|Drug type||DNA-repair enzyme inhibitor|
|How the drug is given||Intravenously (IV)|
Teniposide is FDA approved along with other medicines as induction therapy to treat people who have refractory childhood acute lymphoblastic leukemia, non-Hodgkin lymphoma and other types of cancer. This medicine often causes a temporary loss of hair. After treatment with teniposide has ended, normal hair growth should return.
Side effects needing medical attention:Chills (severe); fever; hives; palpitations; difficulty breathing; dizziness; weakness; facial flushing; unusual tiredness or fatigue; unusual bruising or bleeding; rash; sores on mouth or lips; diarrhea; nausea; vomiting. It is important to tell your healthcare provider right away if redness, pain, swelling or a lump under the skin occurs in the area where the injection is given.